Arich Enterprise Co Ltd - Asset Resilience Ratio

Latest as of December 2025: 1.56%

Arich Enterprise Co Ltd (4173) has an Asset Resilience Ratio of 1.56% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 4173 total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

NT$82.13 Million
≈ $2.59 Million USD Cash + Short-term Investments

Total Assets

NT$5.26 Billion
≈ $165.71 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2017–2025)

This chart shows how Arich Enterprise Co Ltd's Asset Resilience Ratio has changed over time. See Arich Enterprise Co Ltd (4173) net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Arich Enterprise Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Arich Enterprise Co Ltd market cap and net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents NT$0.00 0%
Short-term Investments NT$82.13 Million 1.56%
Total Liquid Assets NT$82.13 Million 1.56%

Asset Resilience Insights

  • Limited Liquidity: Arich Enterprise Co Ltd maintains only 1.56% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Arich Enterprise Co Ltd Industry Peers by Asset Resilience Ratio

Compare Arich Enterprise Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Yifeng Pharmacy
SHG:603939
Pharmaceutical Retailers 19.16%
Raia Drogasil S.A
SA:RADL3
Pharmaceutical Retailers 0.08%
Empreendimentos Pague Menos S.A
SA:PGMN3
Pharmaceutical Retailers 0.88%
d1000 Varejo Farma Participações S.A
SA:DMVF3
Pharmaceutical Retailers 0.59%
High Tide Inc
V:HITI
Pharmaceutical Retailers 0.03%
Laobaixing Pharmacy
SHG:603883
Pharmaceutical Retailers 0.01%
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A
SHE:301408
Pharmaceutical Retailers 0.94%
Yunnan Hongxiang Yixintang
SHE:002727
Pharmaceutical Retailers 4.83%

Annual Asset Resilience Ratio for Arich Enterprise Co Ltd (2017–2025)

The table below shows the annual Asset Resilience Ratio data for Arich Enterprise Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 1.56% NT$82.13 Million
≈ $2.59 Million
NT$5.26 Billion
≈ $165.71 Million
+0.02pp
2024-12-31 1.54% NT$109.16 Million
≈ $3.44 Million
NT$7.10 Billion
≈ $223.82 Million
+1.14pp
2023-12-31 0.40% NT$22.44 Million
≈ $707.01K
NT$5.62 Billion
≈ $177.16 Million
+0.07pp
2022-12-31 0.33% NT$16.36 Million
≈ $515.52K
NT$4.94 Billion
≈ $155.73 Million
-0.34pp
2021-12-31 0.67% NT$30.16 Million
≈ $950.08K
NT$4.49 Billion
≈ $141.42 Million
-3.41pp
2020-12-31 4.08% NT$161.09 Million
≈ $5.08 Million
NT$3.95 Billion
≈ $124.38 Million
+2.50pp
2019-12-31 1.58% NT$59.31 Million
≈ $1.87 Million
NT$3.76 Billion
≈ $118.40 Million
-0.01pp
2018-12-31 1.59% NT$74.85 Million
≈ $2.36 Million
NT$4.71 Billion
≈ $148.43 Million
+0.08pp
2017-12-31 1.51% NT$80.53 Million
≈ $2.54 Million
NT$5.33 Billion
≈ $167.95 Million
--
pp = percentage points

About Arich Enterprise Co Ltd

TWO:4173 Taiwan Pharmaceutical Retailers
Market Cap
$44.52 Million
NT$1.41 Billion TWD
Market Cap Rank
#22321 Global
#1384 in Taiwan
Share Price
NT$18.95
Change (1 day)
-0.52%
52-Week Range
NT$18.95 - NT$25.35
All Time High
NT$27.40
About

Arich Enterprise Co., Ltd. engages in the marketing, promotion, and distribution of pharmaceuticals in Taiwan. It offers sales promotion services for prescription and instruction medications, and health consumer products; and warehousing and distribution logistics services for prescription and instruction medications, controlled drugs, cold chain products, clinical trial products, consumer health… Read more